Access to this 750 microgram Injection Teriparatide formulation within Australia is presently . While it is approved for use to treat osteoporosis, distribution of this specific formulation are relatively restricted . Prescribers could need to seek individual approval via the appropriate pathway to obtain it for their patients . A crucial point tha